Respiratory Medicine News

Mortality in the United States has returned to pre-COVID-19 pandemic levels for the most part, but several groups continue to experience disparities that existed before March 2020, according to a study.

Seven U.S. states have a prevalence of adult long COVID that surpasses 8.8%, according to survey data published by the CDC.

More than three-quarters of people with mild COVID-19 reported experiencing insomnia after recovery, and it was more common among those with anxiety or depression, according to the results of a survey.

An estimated 5.8 million children in the United States have had long COVID, which may occur in up to 20% of children infected with SARS-CoV-2, according to the authors of a new state-of-the-art narrative review published in Pediatrics.

Influenza vaccine manufacturers in the United States said this week that they have plans to remove a potentially extinct influenza B lineage from their vaccines and offer only trivalent shots next season.

Infants aged younger than 3 months and children with a history of prematurity experience the highest rates of hospitalization for respiratory syncytial virus, according to study findings published in Pediatrics.

The updated COVID-19 vaccines were approximately 54% effective against symptomatic SARS-CoV-2 infection and offered protection against JN.1 and XBB viral lineages, according to early estimates published Thursday by the CDC.

Three or more doses of maternal COVID-19 vaccine significantly enhance antibody concentrations in preterm infants compared with two or fewer doses, according to study results published in JAMA Network Open.

COVID-19 vaccination reduces the risk for long COVID in children, according to findings from a study of more than 1 million children published in Pediatrics.

Treating infants with azithromycin at well-child visits did not reduce mortality during a yearslong study in Burkina Faso, according to findings published Wednesday in The New England Journal of Medicine.